Arbutus Biopharma Corporation

ABUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jan 16, 2026 FORM 8-K
8-K Dec 11, 2025 FORM 8-K
8-K Nov 13, 2025 FORM 8-K
10-Q Nov 13, 2025 10-Q
8-K Oct 7, 2025 FORM 8-K
8-K Sep 10, 2025 FORM 8-K
SCHEDULE 13G Aug 13, 2025
4 Aug 6, 2025 FORM 4
3 Aug 6, 2025 FORM 3
10-Q Aug 6, 2025 10-Q
8-K Aug 6, 2025 FORM 8-K
8-K Jun 25, 2025 FORM 8-K
8-K May 23, 2025 8-K
10-Q May 14, 2025 10-Q
8-K May 14, 2025 FORM 8-K
8-K May 7, 2025 FORM 8-K
8-K Apr 23, 2025 FORM 8-K
144 Apr 21, 2025
144 Apr 15, 2025
DEFA14A Apr 4, 2025 DEFA14A
DEF 14A Apr 4, 2025 DEF 14A
8-K Apr 3, 2025 8-K
4/A Apr 1, 2025 FORM 4/A
4 Mar 31, 2025 FORM 4
3 Mar 31, 2025 FORM 3
← Newer Page 3 of 43 · 1054 filings Older →